Randomized trial · people
Thymosin Beta-4: no serious adverse events in healthy volunteers
Checked against the paper Randomized trialPublished by PepVault
The takeaway
This is the first human safety data for lab-made thymosin beta-4 given into a vein. It was well tolerated in healthy volunteers, but this study says nothing about benefit.
- Kind
- Randomized trial
- Studied in
- People
- Published
- 2021
- Journal
- J Cell Mol Med
What they tested
The team tested whether a lab-made version of human thymosin beta-4, called NL005, is safe and tolerable when given into a vein, and how it moves through the body.
How the study was done
A randomized, double-blind phase I trial in healthy Chinese volunteers. In the single-dose part, 54 people in seven cohorts got one dose (0.05 to 25.0 μg/kg) or placebo, a dummy treatment, and were followed for 28 days. In the multiple-dose part, 30 people in three cohorts (0.5, 2.0 and 5.0 μg/kg) got a dose once a day for 10 days and were followed for 28 days.

What they found
Side effects were mild to moderate. No dose caused dose-limiting toxicity, meaning side effects severe enough to stop raising the dose, and there were no serious adverse events. Blood levels, including Cmax (the peak level) and AUC (total exposure over time), rose as the dose went up. Clearance from the body looked similar across doses, and the drug did not clearly build up after 10 daily doses.
What it doesn’t show
This was an early safety study in healthy people, so it did not test whether the drug treats any condition. It used only doses given into a vein, in small cohorts followed for 28 days.
The paper
Wang et al. A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. J Cell Mol Med. 2021.
The compound
More studies on Thymosin Beta-4
- Thymosin beta-4: no overall infarct area cut in 96 STEMI patientsRandomized trial · people · 2025
- Thymosin Beta-4: 42-1260 mg into a vein well tolerated for 14 daysRandomized trial · people · 2010
- Thymosin beta-4 in pregnant mice: longer newborns, more mature organsAnimal study · mice · 2021
- Thymosin beta-4 raised survival in mice with a coronavirus infectionAnimal study · mice · 2021
- Thymosin beta-4: more liver fibrosis in mice bred to make extra TB4Animal study · mice · 2017
- Thymosin beta-4 sped skin wound healing in diabetic and aged miceAnimal study · mice · 2003
- Every study on Thymosin Beta-4
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.